Injectio for inhibiting platelet aggregation and its preparation process
A technology for platelet aggregation and injection, which is applied in blood diseases, pharmaceutical formulations, extracellular fluid diseases, etc. It can solve the problems of easy generation of insoluble particles, and achieve the effect of inhibiting platelet aggregation and stabilizing platelet aggregation.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0010] Embodiment 1 prescription large volume injection of the present invention
[0011] Tirofiban Hydrochloride 5.618g
[0012] Sodium chloride 900g
[0013] Water for injection up to 100000ml
[0014] A total of 1000 bottles of injection were made
[0015] Preparation Process:
[0016] Preparation of liquid medicine:
[0017] Weigh sodium chloride according to the prescription amount, add it to 5000ml of water for injection, stir until completely dissolved; weigh 0.3% activated carbon in solution, stir well, heat and boil for 15 minutes, after cooling, filter out the activated carbon; accurately weigh according to the prescription amount Dissolve tirofiban hydrochloride completely with water for injection, add it to the above sodium chloride solution, and add water for injection to nearly full amount; use 0.1% hydrochloric acid to adjust the pH to 5.5-6.5, add water for injection to the specified amount, and measure the intermediate content It should be 93.0% to 107.0%...
test approach 1
[0048] The test samples were tested before and after sterilization, and then operated according to the following method: put the samples into the constant temperature sample retention observation box, store them at 60°C, take out the samples on the 5th and 10th days respectively, and conduct a full inspection.
[0049] Under the heating condition of 60°C, the injection stability comparison between the prescription of the present invention and the prescription containing citrate buffer
[0050]
test approach 2
[0052] Test the test samples before and after sterilization, and then operate according to the following method: keep the samples at room temperature for observation, take out the samples at 24 months, and check the pH and clarity.
[0053] Under the condition of 24 months, the injection stability comparison of the prescription of the present invention and the prescription containing citrate buffer
[0054]
[0055] Conclusion: the comparison between the prescription of the present invention and the prescription containing citrate buffer. In the test of heating at 60°C for 10 days, the appearance, content, pH, related substances and clarity are all qualified. However, in the investigation of insoluble particles, it was found that the number of particles in the formulation of the present invention was less than that of the formulation containing citrate buffer after 24 months.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com